Target intelligence / Profile preview

L-antigen family member 1 isoform A peptide presented by histocompatibility leukocyte antigen A*02 (LAGE-1A/HLA-A*02:01)

Target
LAGE-1A/HLA-A*02:01
Molecular classification
Peptide-MHC Complex, MHC Class I molecule, Cancer-testis antigen
01

Overview

The L-antigen family member 1 isoform A (LAGE-1A) peptide presented by histocompatibility leukocyte antigen A*02:01 is a tumor-associated antigen complex. LAGE-1A is a cancer-testis antigen overexpressed in various cancers with limited expression in normal tissues, primarily the testis. When presented by HLA-A*02:01, a common MHC class I molecule, it forms an epitope recognized by specific T cell receptors. This complex is a target for immunotherapy approaches, including engineered T cell therapies and bispecific antibodies, to redirect T cells to kill tumor cells expressing this antigen. IMCnyeso is an example of such a therapeutic agent. A potential safety concern is off-tumor toxicity due to LAGE-1A expression in the testis.

Other names
LAGE-1A peptide/HLA-A*02:01 complexNY-ESO-1/LAGE-1A peptide presented by HLA-A*02:01LAGE-1A/HLA-A*02Tumor-associated antigen LAGE-1A/HLA-A*02:01
02

Mechanism of action

T cell redirection and activation

03

Biological functions

Antigen presentationT cell activationTumor cell recognitionImmune response
04

Disease associations

CancerTumor antigen
05

Safety considerations

Off-tumor toxicity due to LAGE-1A expression in testis
06

Interacting drugs

IMCnyeso

2 more in the full profile.

07

Biomarkers

LAGE-1A expressionHLA-A*02:01 positivity

Beyond the preview

Go deeper on L-antigen family member 1 isoform A peptide presented by histocompatibility leukocyte antigen A*02 (LAGE-1A/HLA-A*02:01).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-antigen family member 1 isoform A peptide presented by histocompatibility leukocyte antigen A*02 (LAGE-1A/HLA-A*02:01).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call